Asia Pacific Biotechnology Market Poised to Grow Significantly

The Asia Pacific Biotechnology Market will grow at a CAGR of around 19% during 2010 -2013, estimates RNCOS latest research study.

NOIDA, India (prHWY.com) April 12, 2012 - The biotechnology market has been witnessing a rapid growth in Asia Pacific on back of several factors, including the strong and extensive government support. In the region, countries like India, China and South Korea are emerging fast and robustly evolving their biotechnology industries. According to a recent research report by RNCOS, the wide research and development in the region is creating greater technical advancements, with sound financial assistance backing the sector. In the Asia Pacific biotechnology industry, vaccines and therapeutics represent the most lucrative segments, and agricultural and food biotechnology section is evolving significantly and showing greater innovations. It is anticipated that the market will grow at a CAGR of around 19% during 2010-2013.

The report, "Asia Pacific Biotechnology Market (2008-2012)", says that there are several parallel sectors which are emerging on account of the development in the biotechnology sector. These include contract research and manufacturing, stem cell research and bioinformatics. The Asia Pacific market has shown an increasing trend of adopting biosimilars. The agricultural biotechnology has been playing a vital role in fighting food security issues in the region, which is also becoming the hub for vaccine's R&D and production. Amongst the various nations in Asia Pacific, the Indian and Chinese economies are highly promising and they are expected to dominate the global market in the coming decades. Their role in the low cost manufacturing of vaccines is also magnificent, and holds great potential.

The research study analyzes the biotechnology market in the Asia Pacific region, and provides detailed product and geographical segmentation to clients. Current estimates and forecasts for the industry have been included in the comprehensive report, which also looks into key market trends and opportunities existing for potential investors. By studying the government regulations, the report presents an objective picture of the regulatory environment for the industry. Overall, the research aims to provide a balanced outlook for the Asia Pacific's biotechnology market to the clients.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM138.htm

Some of our Related Reports are:

- Indian Healthcare - New Avenues for Growth (http://www.rncos.com/Report/IM151.htm)
- Insulin Delivery Systems Market Forecast to 2014 (http://www.rncos.com/Report/IM369.htm)
- Global Genetic Testing Market Analysis (http://www.rncos.com/Report/IM352.htm)
- US Diagnostic Market Outlook 2014 (http://www.rncos.com/Report/IM298.htm)
- Global In Vitro Diagnostic Market Analysis (http://www.rncos.com/Report/IM103.htm)

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

About RNCOS:

RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals study and analyze the industry and its various components, with comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the consultants in meeting their objectives in a cost-effective and timely manner.

###

Tag Words: biosimilars

Categories: Health

Press Release Contact
B-129, Sector 6 Noida - 201301
91-120-4224-700
91-120-4224-707

Link To This Press Release:

URL HTML Code